Summary: This executive summary explores the rationale for intranasal drug delivery and the key intranasal drug product formulation design and optimization considerations that can help ensure safe and effective product performance and manufacturability.
Listen to this webinar to hear experts share insights into developing intranasal vaccine analytical tools, how to improve the speed and quality of critical batch release and characterization assays and the importance of device selection in determining product performance.
The aim of this study was to verify if the GastroPlus® PBPK software can be used to predict intranasal absorption by comparing predictions with human intranasal pharmacokinetic data from the literature.
Watch this webinar to gain insights into current market trends in dry powders for inhalation, the key capsule characteristics that determine performance and the fundamental physical characteristics of spray-dried and lactose-based powders that contribute to the efficiency of the encapsulation process.
Summary: In this Q&A article, experts discuss intranasal drug product development, in particular best practices and key considerations, from formulation design to manufacture and scale-up.
Summary: In this Q&A article, Catalent experts Carolyn Berg and Carla Vozone discuss innovations in orally inhaled drug products, in particular dry powders for inhalation.